Impentri
Description
Development of Impentri, an intravenous imatinib formulation for COVID-19 acute respiratory distress syndrome (ARDS)
Accession number
f1a56a78-5f11-11eb-917b-acde48001122
Project acronym
Impentri
Project website
Start date
2020-07-01
End date
2022-06-30
Funding
IMI2 - Call 21 (Grant number 101005142)
Types
